Related Experiment Video
Updated: Jun 17, 2026

05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Delayed-Onset Toxic Anterior Segment Syndrome Combined With Herpes Simplex Keratitis After Cataract Surgery
Kaiming Gu1, Zhipeng Yang, Lu Tang
1Department of Ophthalmology, Mianyang Central Hospital, Mianyang, Sichuan, China.
The Journal of Craniofacial Surgery
|June 16, 2026
Summary
This case report highlights a rare instance of simultaneous toxic anterior segment syndrome (TASS) and herpes simplex keratitis (HSK) occurring after cataract surgery. Prompt diagnosis and combined antiviral and anti-inflammatory treatment led to favorable visual recovery.
Area of Science:
- Ophthalmology
- Medical Case Reports
Background:
- Delayed-onset inflammation after cataract surgery can present diagnostic challenges.
- Toxic Anterior Segment Syndrome (TASS) and Herpes Simplex Keratitis (HSK) are distinct ocular conditions that can affect visual outcomes.
- Differentiating these conditions from infectious endophthalmitis is critical for appropriate management.
Purpose of the Study:
- To report a rare case of simultaneous delayed-onset TASS and HSK following cataract surgery.
- To explore effective diagnosis and treatment strategies for this complex presentation.
- To emphasize the importance of considering multiple etiologies in post-cataract surgery inflammation.
Main Methods:
- Retrospective analysis of a 78-year-old female patient presenting 17 days post-cataract surgery with visual loss and anterior segment inflammation.
- Ocular examination revealed corneal epithelial defect, anterior chamber exudates, and intraocular lens surface exudate.
- Aqueous humor analysis was performed to rule out infectious endophthalmitis, followed by systemic and topical antiviral, anti-inflammatory, and corneal nutritional treatments.
Main Results:
- Aqueous humor pathogen detection did not support infectious endophthalmitis.
- The patient's symptoms gradually improved with treatment, including corneal healing and absorption of exudates.
- Visual acuity in the affected eye recovered to 0.5 (20/40) by 23 days post-discharge.
Conclusions:
- Delayed-onset inflammation post-cataract surgery necessitates vigilance for coexisting multiple causes.
- Excluding infectious endophthalmitis is the crucial first step in diagnosis.
- Combined antiviral and anti-inflammatory treatment, after ruling out infection, can lead to a favorable prognosis.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...

